Thanks to its efforts to develop a COVID-19 vaccine, Novavax Inc. was among the companies that saw its stock price skyrocket over the past year and a half, ever since the search for the vaccine originally began. With that said, its price has recently dropped by quite a bit, which means that it is currently at its bottom.
Since chances are excellent that the price will surge once again, now is the right time to buy Novavax stocks and ride the bullish wave once it arrives. In this guide, we will explain everything, including how, where, and why you should consider doing it.
5 Providers that match your filters
Cost per trade
Fees per trade
67% of retail investor accounts lose money when trading CFDs with this provider.
78.77% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider.
83% of retail investor accounts lose money when trading CFDs with this provider.
There is no guarantee you will make money with this provider. Your capital is at risk.
AvaTrade is a great option, if you want to trade forex, CFDs, and popular cryptos with competitively low spreads and no commissions then . Clients have unfettered access to a demo account as well as the MT4 and MT5 series of platforms.
In This Guide
If you wish to buy Novavax stocks, we can recommend using eToro, as the world’s best stock broker, overall. The process is very quick and simple, and all you need to do is follow 4 simple steps, which include:
Selecting the right broker is half the job when it comes to trading and investing, although doing so is not as easy as it sounds, given how many of them there are. To make matters simpler, we researched all the most popular ones, as well as those less popular, hoping to find some hidden gems, and we have found that there are two brokers that top all others.
The first of the two, and by far the best one available on the market overall, is eToro, as mentioned previously. This broker has been around for almost 15 years, after being founded in 2007. During this time, it has attracted more than 20 million users from all corners of the world.
As an international platform, eToro is also licensed by some of the biggest and most reliable regulatory bodies around the globe, such as the FCA, FINRA, ASIC, and CySEC. Given that these regulators approve of the platform, it is clear that its security and other aspects are up to their standards, which puts eToro among the safest platforms of this kind.
In terms of what it has to offer, we are looking at more than 2,500 trading instruments available (including ETF, shares like Tesla, Apple, etc) for trade and investments, and the best part is that they are all available 100% commission-free. There are spreads that traders need to pay, but even spreads are quite low and affordable. eToro is also attractive to users because it allows you to purchase fractional shares, which means that you can buy only a part of a single share if you wish to go for an expensive one but do not wish to put down too much of your hard-earned money.
Finally, eToro also offers social trading, with its copy-trading feature being the most popular one on the platform. It allows traders to find an expert who trades in the assets they are interested in and then copy their moves instead of trying to figure out what to do themselves.
67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
Alternatively, you can go for Capital.com, which is pretty much the next best thing. This is a platform available in the UK that focuses on trading Contracts For Difference and Spread Betting. You get access to over 3,000 global markets, and this is what has attracted over 360,000 users.
This platform is also heavily regulated by the FCA and CySEC, and the fact that it offers stock CFDs means that you can earn money even when the stock prices are falling, provided that you predicted the drop and entered a position appropriately.
Margin trading is also supported, naturally, and the platform is even easier to use thanks to the fact that it has a minimum deposit of only £20, which is lower than even eToro has to offer. Finally, continuing with the theme of user-friendliness, the platform also features a lot of educational materials, online courses, and other helpful materials.
76.25% of retail investor accounts lose money trading CFDs with this provider.
Now that you know where to buy Novavax stocks, the time has come to decide whether or not you want to do it. You can read 1,000 opinions on whether to do it or not, but in the end, you need to know the facts for yourself and make your own decision. If you don’t know what to look for or what things to pay attention to, we can help with that as well. Here are some of the most important things to keep in mind, and look into when assessing a stock.
Obviously, the first thing that you should ask yourself is what is the company behind the stock that you wish to buy — in this case, Novavax.
Novavax is an American biotechnology company based in Gaithersburg, Maryland, and it creates vaccines that are used for preventing serious infectious diseases. Before 2020, the company’s researchers created a number of experimental vaccines, including the ones for Ebola, respiratory syncytial virus, influenza, and a number of others. However, with the COVID-19 pandemic taking over the entire world in mere weeks back in March 2020, the company focused all its efforts on creating a coronavirus vaccine.
The company did not exactly drop everything else, of course, as it did recognize the need to continue making innovative vaccines in other therapeutic areas. Because of that, it has taken steps to ensure that its nanoflu influenza vaccine will continue to evolve.
Novavax has been around for nearly 35 years now, and at that time, its price has reached major heights several times. Around 2016, however, the Novavax share price crashed to under $50, often fluctuating between this level and $20. Things finally started to change significantly for the company again in April 2020, after its decision to start focusing on the COVID vaccine.
Given the amount of fear and rather strict measures that were introduced in order to combat the pandemic and healthcare in the early days, the companies that were focusing their time and resources on finding a vaccine or a cure were extremely popular, and their services were in high demand. Between March 2020 and February 2021, Novavax's stock price skyrocketed from only $7 to $290.
In 2021, the price saw another correction to $130, which was in mid-May, only to surge to $257 in August, and then crash once again to $145. At the time of writing, it sits at $148.83, after starting another apparent recovery.
Novavax has had some troubles, despite its skyrocketing stock price. While it has been around for decades, it often saw years of annual losses which kept its stock price low, occasionally broken by a price surge such as the one during the COVID pandemic. The company’s struggle to get its vaccine approved is also not helping, neither its stock, revenue, nor reputation as a manufacturer of vaccines.
However, analysts expect that the firm’s $1.95 billion in revenue in 2021 to grow to $5.49 billion in 2022, so there is a reason to be optimistic about the future, even though the company reported a per-share loss of $4.75 and $298 million in sales in its 2nd quarter. All in all, the fundamentals warn that anyone looking to trade or invest in NVAX stock should be cautious, although the company may yet surprise positively.
Novavax currently does not offer a dividend yield, which is not too surprising. Biotech companies usually do not see that much cash flow, which is why they often cannot spare the funds to offer in exchange for investors’ support. This still doesn’t mean that its stocks are not worth investing in, but if you were hoping for passive income from them, this is not the right company to turn to.
Another thing to look into when deciding on whether to invest or not is to look at its ESG.
Regarding the company’s ESG (Environmental, Social, Governance) rating, it does not look too good. Its risk rating is deemed high (31.86) although not quite severe yet. The company is not considered controversial, however - quite the opposite. Its controversy level is 1, while 5 is the worst one, so its performance in this regard is excellent.
In general, Novavax’s ESG ranking is below average, so keep this in mind for the final decision.
Naturally, predicting the prices of stocks is not exactly the most precise art, but it can be done by experts who have knowledge and experience in the field. With that said, the top 5 analysts offering a 12-month price forecast for Novavax have predicted a median price of $272. The stock’s high estimate is $305, while the low one is $200.
From this, it appears that the price and market cap might struggle with growing, but if it should fall again, at least it won’t go too far down, as the support at $200 should keep it from sinking further.
As mentioned, Novavax started its work on the vaccine back in 2020, announcing its involvement back in January. Its vaccine, officially named NVX-CoV2373, is meant to establish immunity against SARS-CoV-2. It is a protein subunit vaccine that contains the spike protein of the virus, and the firm released phase 3 trials a year later, in January 2021.
According to the results, its vaccine was 89% efficient against coronavirus, and it provided strong immunity against new variants, many of which have emerged throughout 2021. Later on, in June 2021, it announced that the efficiency has been improved to 90.4%. Of the total of 77 COVID-19 cases among the volunteers of the clinical-stage trial, 14 cases appeared in the group that received the vaccine, while 63 cases emerged in the placebo group, indicating that the vaccine does help.
Finally, the big question — is Novavax a good buy or not? This is something that you need to decide for yourself by combining all the knowledge up until now. We have seen that the company has done a good job with creating a Novavax Covid-19 vaccine, although it still has issues with having it authorized by drug administration agencies in certain regions. Its ESG is not impressive, but its price surge throughout 2020 certainly was. In 2021, the price has been suffering volatility quite a bit, but it would always grow after each major correction. Right now, everyone is waiting to see whether the vaccine will be authorized by regulators like FDA or receive an emergency use authorization (EUA) by the U.S. government or other countries as it happened with mRNA vaccines such as Moderna or Pfizer. If it does get the green light, the company’s stock price will certainly grow.
Investing with eToro is very simple and quick, and all you need to do to set up your account is follow four quick and simple steps.
The first thing to do is to go to eToro’s platform and create an account. Doing so is completely free, and all you need is an email address. Alternatively, you don’t even need to create a new account from scratch. Instead, you can log in with your Facebook or Google account.
67% of retail investor accounts lose money when trading CFDs with this provider.
After creating an account, you will be required to verify your ID. This is necessary because the regulators request it, and since eToro is regulatory-compliant, it is rather strict about this. But, don’t worry too much about it as it is nothing complicated. All you need to do is upload photos of an official document that has your photo and other details, such as an ID, a passport, or a driver’s license. Also, to confirm your address, you will need to deliver a bank statement that is not older than three months.
Once the verification has been completed, you can proceed with depositing the funds. Doing this is simple as well. Start by clicking the Deposit Funds button in the bottom-left corner of your dashboard, select the desired amount, your preferred payment method, and fill in the rest of the details. Once you are done, hit the Deposit button again, and your funds will be on their way. Note that some payment methods, such as bank transfers, may take a few days to arrive, while others will be there much quicker.
Finally, all that remains is to use the search feature at the top of your dashboard, type in Novavax or NVAX, and select it once it appears in the suggested searches. Once you get to its platform, simply click the trade button, fill out your order, and that is that.
Novavax stock is not the safest investment out there, given the combination of its positives and negatives, but it can certainly open up opportunities to careful investors and traders who know what they are doing. If you are still new to real-time trading, this one might be a bit too risky, but if you already have some experience and are willing to take an increased risk, you can consider buying and selling depending on the price performance.
At this point, you have everything you need in order to invest in Novavax stock or start trading it to make use of the small price fluctuations. Keep in mind the risks and the details regarding the company and its vaccine, which will definitely have a strong impact on the price of the stock. But, when you decide that you wish to make your move and that the time for it has come, simply go to eToro, set up your account, and you will be free to invest at any time you like.
Novavax is a biotechnology company based in the US that develops vaccines that are used around the world to prevent serious infectious diseases.
As a publicly-traded company, Novavax is owned by its shareholders.
Novavax is an American company based in Gaithersburg, Maryland.
At the time of writing (November 1st, 2021) Novavax’s stock price is $148.83 per share.
While opinions regarding any certain stock are always split, more analysts are in favor of buying Novavax stocks right now than there are against it.
The easiest way to buy Novavax stock is on eToro platform, where you can do it without a commission fee.
Ali is an experienced writer covering the cryptocurrency markets and the blockchain industry. He has 8 years of experience writing about cryptocurrencies, technology, and trading. His work can be found in various high-profiled investment sites including CCN, Capital.com, BeInCrypto, Bitcoinist, and NewsBTC.
Best UK Stock, Forex, CFD, Crypto, Social or Day Trading Platform that meets your needs.